feed,title,long_url,short_url
TheStreet,Biogen Stock Drops as ALS Treatment Fails Phase 3 Study,https://www.thestreet.com/investing/biogen-drops-asl-treatment-misses-phase-3-results,https://j.mp/3vkLfMA
